| 4729-0 |
HLA-A29(19) |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-A29(19) [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4729-0 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A29(19) Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47290-2 |
IgG subclass panel |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
IgG subclass panel [Mass/volume] - Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
47290-2 |
|
|
|
|
Order |
|
|
|
0 |
IgG subclass Pnl Ser-mCnc |
|
|
|
N |
|
Chemistry; IgG subclass Pnl; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Subclasses; UniversalLabOrders |
2.73 |
2.19 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 47291-0 |
Fungus^^^6 |
Prid |
XXX |
Pt |
Nom |
Culture |
|
ACTIVE |
Fungus # 6 identified in Specimen by Culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
47291-0 |
|
Culture |
|
|
Observation |
|
|
|
0 |
Fungus Spec Cult org #6 |
|
|
|
N |
|
C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.19 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 47292-8 |
Fungus^^^7 |
Prid |
XXX |
Pt |
Nom |
Culture |
|
ACTIVE |
Fungus # 7 identified in Specimen by Culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
47292-8 |
|
Culture |
|
|
Observation |
|
|
|
0 |
Fungus Spec Cult org #7 |
|
|
|
N |
|
C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.19 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 47293-6 |
Bacteria^^^7 |
Prid |
Genital |
Pt |
Nom |
Aerobic culture |
|
ACTIVE |
Bacteria # 7 identified in Genital specimen by Aerobe culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
47293-6 |
|
Aerobic culture |
|
|
Observation |
|
|
|
0 |
Bacteria Genital Aerobe Cult org #7 |
|
|
|
N |
|
Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; Gen; Genital tract; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Urogenit; Urogenital |
2.78 |
2.19 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 47294-4 |
Bacteria^^^7 |
Prid |
Wound.shlw |
Pt |
Nom |
Aerobic culture |
|
ACTIVE |
Bacteria # 7 identified in Wound shallow by Aerobe culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
47294-4 |
|
Aerobic culture |
|
|
Observation |
|
|
|
0 |
Bacteria Shlw Wnd Aerobe Cult org #7 |
|
|
|
N |
|
Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Shlw Wnd; Wnd; Wound - shallow |
2.78 |
2.19 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 47295-1 |
Bacteria^^^8 |
Prid |
Wound.shlw |
Pt |
Nom |
Aerobic culture |
|
ACTIVE |
Bacteria # 8 identified in Wound shallow by Aerobe culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
47295-1 |
|
Aerobic culture |
|
|
Observation |
|
|
|
0 |
Bacteria Shlw Wnd Aerobe Cult org #8 |
|
|
|
N |
|
Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Shlw Wnd; Wnd; Wound - shallow |
2.78 |
2.19 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 47296-9 |
Clostridium tetani toxoid Ab^2nd specimen/1st specimen |
Ratio |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Clostridium tetani toxoid Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
47296-9 |
|
|
|
|
Both |
|
|
|
0 |
C tetani Toxoid Ab 2:1 Ser-Rto |
|
|
|
N |
|
2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C tetani; C tetani Toxoid; c12; c208; Convalescent; First; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rc208; Rto; Second; Serum; sp1; sp2; Spec; SR; Tet; Tetanus; Tetanus toxoid; Ttx |
2.64 |
2.19 |
|
|
|
|
|
|
|
|
|
|
Corrected the word "toxin" in the Component to "toxoid" to more precisely represent what is being measured. |
0 |
| 47297-7 |
Corynebacterium diphtheriae toxin Ab^1st specimen |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Corynebacterium diphtheriae toxin Ab [Units/volume] in Serum by Immunoassay --1st specimen |
|
MIN |
DefinitionDescription |
|
|
IU/mL |
|
|
|
|
|
|
MICRO |
|
47297-7 |
|
IA |
|
|
Both |
|
|
|
0 |
C diphtheriae Tox Ab sp1 Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C diphtheriae; C diphtheriae Tox; Diphtheria; Diptheria; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Serum; sp1; Spec; SR; SUDS |
2.73 |
2.19 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47298-5 |
Corynebacterium diphtheriae Ab^2nd specimen/1st specimen |
Ratio |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Corynebacterium diphtheriae Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
47298-5 |
|
|
|
|
Observation |
|
|
|
0 |
C diphtheriae Ab 2:1 Ser-Rto |
|
|
|
N |
|
2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C diphtheriae; Convalescent; Diphtheria; Diptheria; First; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Post immunization; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Second; Serum; sp1; sp2; Spec; SR |
2.69 |
2.19 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
| 47299-3 |
DNA double strand Ab |
ACnc |
Ser |
Pt |
Qn |
Farr |
|
ACTIVE |
DNA double strand Ab [Units/volume] in Serum by Farr method |
|
MIN |
DefinitionDescription |
|
|
IU/mL |
|
|
|
|
|
|
SERO |
|
47299-3 |
|
Farr |
|
|
Both |
|
|
|
0 |
dsDNA Ab Ser Farr-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Native DNA; N-DNA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Stranded; Strnd |
2.73 |
2.19 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
|
0 |
| 473-9 |
sulfiSOXAZOLE |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
sulfiSOXAZOLE [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
473-9 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Sulfisoxaz Islt KB |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Gantrisin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sulfizole; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4730-8 |
HLA-A2 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-A2 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4730-8 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A2 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47300-9 |
Phosphatidate Ab.IgM |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Phosphatidate IgM Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
Index |
|
|
|
|
|
|
COAG |
|
47300-9 |
|
IA |
|
|
Both |
|
|
|
0 |
Phosphatidate IgM Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; aPA; Arbitrary concentration; Autoantibodies; Autoantibody; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Immune globulin M; Immunoglobulin M; MEIA; PA; Phosphatidic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS |
2.73 |
2.19 |
|
|
|
|
|
|
|
{Index_val} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47301-7 |
Ribosomal P Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Ribosomal P Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
47301-7 |
|
IA |
|
|
Both |
|
|
|
0 |
Ribosomal P Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribosomal P Protein; Rib-P; RPP; Serology; Serum; SR; SUDS |
2.73 |
2.19 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47302-5 |
(Allium cepa+Allium sativum+Apium graveolens+Lycopersicon lycopersicum+Yeast) Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
Multidisk |
|
ACTIVE |
Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Units/volume] in Serum by Multidisk |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
Reference range: <.35 |
|
|
|
|
|
ALLERGY |
|
47302-5 |
|
Multidisk |
|
|
Both |
|
|
|
0 |
Food Allerg Mix7 IgE Qn |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Allium salota Dost�¡l; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Celery; f047; f048; f085; f25; f47; f48; f85; Food Allerg Mix7; fx7; Garlic; Immune globulin E; Immunoglobulin E; Lycopersicon esculatum; Lycopersicon lycopersicon; Onion; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tomato |
2.7 |
2.19 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 47303-3 |
Anaplastic lymphoma kinase Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Anaplastic lymphoma kinase Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
47303-3 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
ALK Ag Tiss Ql ImStn |
|
|
|
N |
|
ALK; ALK Ag; ALK protein; ALK1; Antigen; Antigens; CD246; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.73 |
2.19 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47304-1 |
Borrelia burgdorferi Ab.IgG index |
ACnc |
Ser+CSF |
Pt |
Qn |
|
|
ACTIVE |
Borrelia burgdorferi IgG Ab index [Units/volume] in Serum and CSF |
|
MIN |
DefinitionDescription |
|
|
|
Reference range: <1.0 |
|
|
|
|
|
MICRO |
|
47304-1 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgG Index Ser+CSF-aCnc |
|
|
|
N |
|
ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Both serum and cerebrospinal fluid; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR |
2.73 |
2.19 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 47305-8 |
BRST 2 Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
BRST 2 Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
47305-8 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
BRST 2 Ag Tiss Ql ImStn |
|
|
|
N |
|
Antigen; Antigens; GCDFP 15; Gross Cyctic Disease Fluid Protein; IHC; II; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.73 |
2.19 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47306-6 |
Cartilage oligomeric matrix protein |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Cartilage oligomeric matrix protein [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
Reference range: <15.1 |
|
|
|
|
|
SERO |
|
47306-6 |
|
IA |
|
|
Both |
|
|
|
0 |
COMP Ser IA-aCnc |
|
|
|
N |
|
Arbitrary concentration; COMP; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS |
2.7 |
2.19 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47307-4 |
Cytomegalovirus Ab.IgG Index |
ACnc |
Ser+CSF |
Pt |
Qn |
|
|
ACTIVE |
Cytomegalovirus IgG Ab index [Units/volume] in Serum and CSF |
|
MIN |
DefinitionDescription |
|
|
|
Reference range: <0.8 |
|
|
|
|
|
MICRO |
|
47307-4 |
|
|
|
|
Both |
|
|
|
0 |
CMV IgG Index Ser+CSF-aCnc |
|
|
|
N |
|
ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; CMV; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR |
2.73 |
2.19 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 47308-2 |
Echinococcus granulosus Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Echinococcus granulosus IgG Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
Index |
Reference range: <0.8 |
|
|
|
|
|
MICRO |
|
47308-2 |
|
IA |
|
|
Both |
|
|
|
0 |
E granulosus IgG Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; E granulosus; Echinococcosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS |
2.73 |
2.19 |
|
|
|
|
|
|
|
{Index_val} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47309-0 |
Haemophilus influenzae B Ab.IgG^2nd specimen/1st specimen |
Ratio |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Haemophilus influenzae B IgG Ab [Ratio] in Serum --2nd specimen/1st specimen |
|
MIN |
DefinitionDescription |
|
|
|
Reference range: >4.0 |
|
|
|
|
|
MICRO |
|
47309-0 |
|
|
|
|
Observation |
|
|
|
0 |
Haem influ B IgG 2:1 Ser-Rto |
|
|
|
N |
|
2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; H flu; H influenza; H influenzae; Haem influ; Haem influ B; Haemoph; HIB; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Influ; Microbiology; Point in time; Post immunization; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Second; Serum; sp1; sp2; Spec; SR |
2.7 |
2.19 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4731-6 |
HLA-A2 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-A2 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4731-6 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A2 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47310-8 |
Haemophilus influenzae B Ab.IgG^1st specimen |
MCnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
MIN |
DefinitionDescription |
|
|
mg/L |
Reference range: >.15 |
|
|
|
|
|
MICRO |
|
47310-8 |
|
IA |
|
|
Both |
|
|
|
0 |
Haem influ B IgG sp1 Ser IA-mCnc |
|
|
|
N |
|
ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; H flu; H influenza; H influenzae; Haem influ; Haem influ B; Haemoph; HIB; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Influ; Level; Mass concentration; MEIA; Microbiology; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Serum; sp1; Spec; SR; SUDS |
2.7 |
2.19 |
|
|
|
|
|
|
|
mg/L |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
